EW

Healthcare Medical Devices

Edwards Lifesciences Corporation

$85.15
-0.04 -0.05% today

Price History

Not enough data

Key Stats

Market Cap
49.03B
Avg Volume
3.85M
P/E (TTM)
50.68
EPS
$1.68
52W High
$96.29
52W Low
$72.30
Div. Yield
0.0%

Analyst Ratings

Buy
4
Str Buy
18
Buy
7
Hold
0
Sell
0
Str Sell

Valuation

Forward P/E
25.21
P/B Ratio
4.62
P/S Ratio
7.53
EV/EBITDA
22.86
EV/Revenue
7.01
PEG Ratio
1.82

Margins

Gross Margin 77.8%
Operating Margin 29.8%
Net Margin 15.4%
EBITDA Margin 30.7%

Growth & Returns

Revenue Growth (YoY)
13.6%
Earnings Growth (YoY)
(25.4%)
Earnings Growth (QoQ)
(27.4%)
Return on Equity
9.2%
Return on Assets
8.4%

Liquidity & Leverage

Current Ratio
4.52
Quick Ratio
3.45
Debt / Equity
0.07
Total Cash
4.25B
Total Debt
704.40M

About

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

www.edwards.com